AzTrials
AzTrials

Lumbar ArthrodesisECALAPNCT04115202

Comparative Study of the Results of Anterior and Posterior Arthrodesis in Degenerative Lumbar Pathology

An observational study of Lumbar Arthrodesis, run by GCS Ramsay Santé pour l'Enseignement et la Recherche at 1 site in France.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

To compare the functional results through the improvement of the Oswestry medium-term score of the lumbar arthrodesis performed to treat patients with lumbago and/or lumbar-radicular pain due to degenerative lesions of the lumbar spine: degenerative disc disease, osteoarthritis spondylolisthesis or adult dislocation… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Lumbar Arthrodesis
What is being tested?
lumbar arthrodesis
Type of treatment
Surgery or procedure
How many people
254 participants
Where
1 siteFrance
Study dates
31 May 2018to 31 Jul 2020
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: patients with a degenerative lumbar pathology operated

Who may be able to join

  • Patient requiring a lumbar arthrodesis to be carried out by one of the seven investigative surgeons of the Geoffroy Saint Hilaire Clinic IPAD study.
  • At least 18 years old (no upper age limit).
  • Patient with chronic lumbago or lumbar radiculopathy and resistant to a conservative medical treatment sufficiently carried out for at least 6 months, included alongside the usual analgesic, anti-inflammatory, infiltration and rehabilitation contraindications.
  • Patient whose lumbar and/or radicular VAS is greater than or equal to 50 mm
  • Patient whose Oswestry Index is greater than or equal to 40%
  • Patient responding on one anatomical level* to one of the following diagnoses:
Show all 12Show fewer
  • Spondylolisthesis or degenerative retrolisthesis or
  • single stage dislocation on scoliosis or
  • degenerative disc disease without true disc herniation, without deformity and instability reaching a single anatomical level
  • *single-stage pathology located between L1 and the sacrum (1 stage = 2 vertebrae and an intervertebral disc).
  • Patient with health insurance or beneficiary of a social security scheme
  • Patient having been informed of and having agreed to the use of their health data (non-opposition)

Who cannot join

  • - Any situation that is a contraindication to either surgical approach. For example, for the anterior approach: morbid obesity, a history of multiple abdomen surgical procedures, aneurysm of the operated abdominal aorta making retroperitoneal dissection dangerous, severe arteritis with risk of mobilisation of aortoiliac atheromatous plaque, previous radiotherapy (radiation in the path of the approach).
  • Contraindication to the strategy under study or an act of evaluation: for example contraindication to imagery provided (Pace maker for MRI).
  • Pathology located in L1L2 which against indicates the previous conventional approaches (need to disinsert the diaphragm).
  • Patient with proven osteoporosis: femoral T-score > -2 SD (measurement of the lumbar spine is not relevant because disturbed by osteoarthritic phenomena with vertebral osteo-condensation) and imposing a circumferential arthrodesis: anterior and posterior.
  • Patient with excluded disc herniation: hernia that cannot be removed by anterior route (NB: A simple hernia is not a non-inclusion criterion).
  • Association with the single-stage pathology another lumbar lesion imposing to extend the act of arthrodesis and/or decompression to one or more spinal stages.
Show all 11Show fewer
  • Any situation that could interfere with the follow-up of this study, i.e. psychological instability, personal situation hindering the follow-up of the study).
  • Patient having undergone lumbar surgery less than one year ago
  • Protected patients: adults under guardianship, trusteeship or other legal protection, deprived of liberty by judicial or administrative decision
  • Pregnant, lactating or parturient women
  • Individuals hospitalised without consent.

Trial locations and contacts

1 site in 1 country.

France1 site, 1 recruiting
  • Geoffroy Saint Hilaire Clinic

    Paris, IDF, 75005

    Jean Francois OUDET, jeanfrancois.oudet@free.fr

    Marie Barba, +330664888704 ext. +330664888704, mh.barba@ecten.eu

    Recruiting

Other trials in France

About this study

To compare the functional results through the improvement of the Oswestry medium-term score of the lumbar arthrodesis performed to treat patients with lumbago and/or lumbar-radicular pain due to degenerative lesions of the lumbar spine: degenerative disc disease, osteoarthritis spondylolisthesis or adult dislocation scoliosis.

Read the detailed description

Lower back pain is the leading cause of disability in France for adults under 45 years of age. It is also the leading cause of work stoppage and reported occupational illnesses. Thus, the degenerative pathologies of the lumbar spine can be at the origin of a severe handicap resistant to well-conducted medical treatment. This is particularly the case for degenerative disc disease, osteoarthritic spondylolisthesis and scoliotic dislocations in adults.

If lumbar arthrodesis is a recognised solution in the surgical treatment of degenerative diseases of the lumbar spine when they become disabling despite medical treatment, the choice of the operative technique and approach used to achieve it is more dependent of the training that the practitioner benefited from than the guidelines derived from published prospective comparative scientific studies comparing the results of different surgical solutions.

Our hypothesis is that the functional and radiographic results of anterior lumbar arthrodesis techniques by minimally invasive approach may differ from those of conventional posterolateral arthrodesis.

We propose to compare the results of these two surgical techniques within the orthopedic and neurosurgeon team of the Institut Parisien du Dos, mastering these two approaches optimally by leaving them free to use them as they do daily without modifying their procedures. This should allow us to judge, in a well-defined population, whether one of the two techniques is superior to the other when performed by surgeons who are experienced in this surgery.

Being tested
lumbar arthrodesis
Medical subject headings
Ankylosis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • lumbar arthrodesisProcedure or surgery

    two approaches anterior versus posterior, optimally by leaving physicians free to use them as they do daily without modifying their procedures

Study groups in NCT04115202
Study groupRoleWhat they receive
posterior spinal approach groupLumbar arthrodesis performed by a posterior spinal approach.
Receives: Procedure: lumbar arthrodesis
anterior spinal approach groupLumbar arthrodesis performed by a anterior spinal approach.
Receives: Procedure: lumbar arthrodesis

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Oswestry medium-term score

    The absolute value and improvement of the Oswestry score at 1 year compared to the preoperative score for the 2 populations of lumbar arthrodesis by anterior or posterior approach.

    Measured: 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Oct 2019
  2. Study start31 May 2018
  3. Primary completion31 Jul 2020 (estimated)
  4. Study completion31 Jul 2020 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
254 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04115202
Sponsor's protocol ID
2017-A02319-44
Acronym
ECALAP
Status last verified
Oct 2019
First submitted
2 Oct 2019
Last updated
3 Oct 2019
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

An observational study of Lumbar Arthrodesis, run by GCS Ramsay Santé pour l'Enseignement et la Recherche at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 12 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 3 Oct 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Jean Francois OUDET (+33683346567, jeanfrancois.oudet@free.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Oswestry medium-term score (time frame: 12 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Oct 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in